Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (339)	12/11/1999 10:40:00 PM
From: Pseudo Biologist	Read Replies (2) \| Respond to of 3557

...What you mean by most recent data? Obviously, not the most recent -g- Did I say I did not know enough facts? I was talking of the herpes virus side effect revealed a few months ago in a PR. High potency is always encouraging. Darned, I'll have to hit the books again. Let me add that the Yancopoulos body of work on angiogenesis is extremely rich, very hard, for me, to follow, but something bound to yield some very interesting stuff one of these days. I do not mean just beautiful papers in Nature or Science, there are plenty of those already -g- Last, thanks for the kind words. PB